Off-Label Prescribing and Polypharmacy Minimizing the Risks

被引:0
|
作者
Leahy, Laura G. [1 ,2 ]
机构
[1] APNSolut LLC, 123 Egg Harbor Rd,Suite 703, Sewell, NJ 08080 USA
[2] APNSolut LLC, Psychopharmacol, 123 Egg Harbor Rd,Suite 703, Sewell, NJ 08080 USA
关键词
RANDOMIZED-CONTROLLED-TRIALS; DRUG-USE; DISORDER; MULTICENTER; TOPIRAMATE; PRAZOSIN;
D O I
10.3928/02793695-20170210-02
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Off-label prescribing and polypharmacy are commonplace in today's health care environment. Patients are treated with multiple medications obtained through multiple providers, and all too frequently, there is no collaboration amongst professionals. Nurses can address these issues by educating themselves and their patients regarding medication indications and uses, side effects, risks, and benefits. By exploring a patient's medication reconciliation, including over-the-counter agents, and identifying the U.S. Food and Drug Administration-approved indications, as well as potential off-label uses and overlapping side effects of the medications prescribed, nurses can facilitate collaboration among prescribers to reduce polypharmacy, minimize medication side effects, and alleviate drug-drug interactions, while improving patient outcomes and quality of life. [Journal of Psychosocial Nursing and Mental Health Services, 55(2), 17-22.]
引用
收藏
页码:17 / 22
页数:6
相关论文
共 50 条
  • [1] Off-label prescribing
    Raknes, Guttorm
    [J]. TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2016, 136 (04) : 335 - 335
  • [2] Off-label prescribing
    Gazarian, Madlen
    Morris, Steve
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2014, 200 (11) : 637 - 637
  • [3] Off-label prescribing
    Seale, J. Paul
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2014, 200 (02) : 65 - 65
  • [4] Off-label prescribing
    Kelly, Maria
    Gazarian, Madlen
    McPhee, John
    [J]. AUSTRALIAN PRESCRIBER, 2005, 28 (01) : 7 - 7
  • [5] OFF-LABEL PRESCRIBING OF ANTIDEPRESSANTS Robust systems are needed for off-label prescribing
    Ross, Samantha
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2017, 356
  • [6] The Perils of Off-Label Prescribing
    Buppert, Carolyn
    [J]. JNP-JOURNAL FOR NURSE PRACTITIONERS, 2012, 8 (07): : 567 - 568
  • [7] Off-label prescribing in oncology
    Susan G. Poole
    Michael J. Dooley
    [J]. Supportive Care in Cancer, 2004, 12 : 302 - 305
  • [8] Off-Label Prescribing: Justified or Not?
    Ruan, Xiulu
    Kaye, Alan David
    [J]. AMERICAN JOURNAL OF MEDICAL QUALITY, 2016, 31 (02) : 101 - 102
  • [9] The challenge of off-label prescribing
    Phillips, Jane
    [J]. INTERNATIONAL JOURNAL OF PALLIATIVE NURSING, 2015, 21 (09) : 419 - 419
  • [10] Off-label prescribing in oncology
    Poole, SG
    Dooley, MJ
    [J]. SUPPORTIVE CARE IN CANCER, 2004, 12 (05) : 302 - 305